BioNTech SE's total assets for Q1 2026 were €21.10B, a decrease of -4.02% from the previous quarter. BNTX total liabilities were €2.38B for the fiscal quarter, a -13.91% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.